Land: Israel
Sprog: engelsk
Kilde: Ministry of Health
ABIRATERONE ACETATE
MEDOMIE PHARMA LTD, ISRAEL
L02BX03
TABLETS
ABIRATERONE ACETATE 250 MG
PER OS
Required
MSN LABORATORIES PRIVATE LIMITED, INDIA
ABIRATERONE
a CYP17 inhibitor indicated:- in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer.- for the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mHSPC) in adult men in combination with androgen deprivation therapy (ADT)
2023-08-31
PATIENT PACKAGE INSERT IN ACCORDANCE WITH THE PHARMACISTS’ REGULATIONS (PREPARATIONS) - 1986 This medicine is dispensed with a doctor’s prescription only ABIRATERONE MEDOMIE 250 MG TABLETS ACTIVE INGREDIENT AND ITS QUANTITY Abiraterone acetate 250 mg, equivalent to 223 mg of abiraterone . Inactive ingredients and allergens in the preparation – see section 2 “Important information about some of the medicine’s ingredients” and section 6 “Further Information”. READ THIS LEAFLET CAREFULLY IN ITS ENTIRETY BEFORE USING THE MEDICINE. This leaflet contains concise information about the medicine. If you have further questions, consult your doctor or pharmacist. This medicine has been prescribed to treat your illness. Do not pass it on to others. It may harm them even if it seems to you that their illness is similar. 1. WHAT IS THIS MEDICINE INTENDED FOR? Abiraterone Medomie 250 mg is a prescription medicine containing an active ingredient called abiraterone acetate. Abiraterone Medomie 250 mg is a CYP17 enzyme inhibitor, given in combination with prednisone for the treatment of: • metastatic castration-resistant prostate cancer. • adult males with newly diagnosed high risk metastatic hormone-sensitive prostate cancer (mHSPC) in combination with androgen deprivation therapy (ADT). THERAPEUTIC GROUP: Specific inhibitor of the enzyme CYP17. 2. BEFORE USING THE MEDICINE DO NOT USE THIS MEDICINE: • If you are sensitive (allergic) to abiraterone acetate or to any of the additional ingredients contained in the medicine. For a list of the additional ingredients, see section 6 “Further Information”. • If you are a woman, especially a pregnant woman. Abiraterone Medomie 250 mg is intended for use in males only. • If you suffer from severe liver damage. • In combination with Ra-223 (used to treat prostate cancer). Do not take the medicine if any of the above applies to your condition. If you are not sure, consult with your doctor or pharmacist before taking the medicine. SPECIAL WARNINGS REGARDING THE Læs hele dokumentet